MENU
+Compare
RLFTF
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$3.43
Change
-$0.05 (-1.44%)
Capitalization
43.11M

RLFTF RELIEF THERAPEUTICS HLDG AG Forecast, Technical & Fundamental Analysis

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products... Show more

RLFTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RLFTF with price predictions
Nov 28, 2025

Momentum Indicator for RLFTF turns negative, indicating new downward trend

RLFTF saw its Momentum Indicator move below the 0 level on November 18, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 111 similar instances where the indicator turned negative. In of the 111 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

RLFTF moved below its 50-day moving average on November 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RLFTF crossed bearishly below the 50-day moving average on November 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RLFTF's RSI Oscillator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where RLFTF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RLFTF just turned positive on November 28, 2025. Looking at past instances where RLFTF's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RLFTF advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

RLFTF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.064) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (8.532) is also within normal values, averaging (321.020).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RLFTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLFTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
RLFTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Avenue de Secheron 15
Phone
+41 447235959
Employees
50
Web
https://www.relieftherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKRIY18.74N/A
N/A
Bank Ireland Group PLC
JBFCF3.46N/A
N/A
Jollibee Foods Corp.
SOLTF5.98N/A
N/A
Nxera Pharma Co.,Ltd.
TTNMF0.94N/A
N/A
Titanium Transportation Group
LINMF0.04N/A
N/A
LINEAR MINERALS CORP.

RLFTF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTF has been loosely correlated with RLFTY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTF jumps, then RLFTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTF
1D Price
Change %
RLFTF100%
N/A
RLFTY - RLFTF
44%
Loosely correlated
N/A
ORKA - RLFTF
30%
Poorly correlated
+0.56%
DRUG - RLFTF
21%
Poorly correlated
+0.68%
PCVX - RLFTF
20%
Poorly correlated
-1.80%
ONTTF - RLFTF
17%
Poorly correlated
N/A
More